Temozolomide 3 weeks on and 1 week off as first-line...

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)

Brandes, A A, Tosoni, A, Cavallo, G, Bertorelle, R, Gioia, V, Franceschi, E, Biscuola, M, Blatt, V, Crinò, L, Ermani, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
95
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6603376
Date:
November, 2006
File:
PDF, 103 KB
english, 2006
Conversion to is in progress
Conversion to is failed